Tasimelteon not checked
Vanda Pharmaceuticals · VEC-162
FollowEvery change as it happens, and a Monday email
Trials
2 active
11 in total · 3 in the EU
What this is
- How it works
- Melatonin Receptor Agonist FDA class
- How it’s given
- “Single daily dose, weight-based liquid suspension formulation.”In the company’s words, NCT06953869 on ClinicalTrials.gov
- Tested for
- Sleep Wake Disorders, Sleep Disorders, Circadian Rhythm, Chronobiology Disorders, Gene Mutations and Other Alterations Nec, Insomnia Disorder
- Main trialPhase 3
- “This is a double-blind, randomized, two-period crossover study to evaluate the efficacy and safety of a single oral dose of tasimelteon and matching placebo in male and female subjects with DSWPD and the CRY1Δ11 variant.”In the company’s words, NCT06701396 on ClinicalTrials.gov
- Other names
- VEC-162 · Hetlioz
Other drugs for Sleep Wake Disorders
- SolriamfetolAxsome Therapeutics, Inc. · Phase 3
Coming up1
- Nov 2027Phase 3 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials11
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Recruiting | 30 Jun 2025 | Evaluating the Effects of Tasimelteon Vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD) and the CRY1Δ11 Variant | |
| Phase 3Recruiting | Nov 2027 | Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia | |
| Phase 3Completed | 5 Mar 2018 | Evaluating the Effects of Tasimelteon vs. Placebo on Jet Lag Type Insomnia | |
| Phase 3Unknown | 5 Dec 2024 | Safety Study of Tasimelteon for Treatment of Non-24-Hour-Sleep-Wake Disorder in Blind Individuals With No Light Perception | |
| Phase 3Unknown | Jul 2025 | Evaluating the Effects of Tasimelteon in Individuals With Autism Spectrum Disorder (ASD) and Sleep Disturbances | |
| Phase 3Completed | 4 Sep 2026 | Evaluating the Effects of Tasimelteon vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD) | |
| Phase 2/3Completed | 19 Nov 2018 | Evaluating the Effects of Tasimelteon vs Placebo on Sleep Disturbances in SMS | |
| Phase 2Completed | Nov 2017 | A Proof of Concept Study to Evaluate the Effects of Tasimelteon and Placebo in Travelers With Jet Lag Disorder | |
| Phase 1Completed | 20 Dec 2017 | Study of the Pharmacokinetics and Safety of Tasimelteon in Children and Adolescents | |
| Phase 1Completed | 28 Aug 2018 | Evaluation of Next-Day Residual Effects of Tasimelteon Compared With Placebo and Active Control in Healthy Subjects | |
| Phase 1Completed | 15 Jun 2022 | Bioequivalence Study Between Tasimelteon Capsule Formulation and Liquid Suspension Formulation in Healthy Volunteers |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026